Tcga
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
If Tcga is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.
What’s changed
- Leveraging deep learning for prognostic stratification of hepatocellular carcinoma using histopathological images · Frontiers Precision Oncology · 2026-09-28
- Novel juxtamembrane FLT3 in-frame insertion in a child with refractory AML: a case report of durable remission following allogeneic HSCT and FLT3 inhibitor therapy · Frontiers Precision Oncology · 2026-09-25
- Beyond molecular classification: integrating signaling, subcellular, and immune reprogramming in endometrial cancer · Frontiers Precision Oncology · 2026-09-25
- Prospective multicenter study evaluating safety, tolerability and metabolism of niraparib as maintenance for ovarian cancer in women of African ancestry · Frontiers Precision Oncology · 2026-09-24
- FJX1 drives FOLFOX resistance via PPARγ-mediated EMT and serves as a prognostic biomarker in colorectal cancer. · Transl Oncol · 2026-09-23
- The deubiquitinating enzyme UCHL3 promotes bladder cancer progression and glycolysis through enhancing PKM2 protein stability · Frontiers Precision Oncology · 2026-09-18
What the reporting says
It shows up alongside Cancer Genome (17), Colorectal Cancer (20), Immunotherapy (10), Commons (10), Atlas (18), Breast Cancer (8), AI (15), Disclaimer (10).
Two steps out: Braf (through Colorectal Cancer, 20 shared stories on the weaker link); ctDNA (through Colorectal Cancer, 20 shared stories on the weaker link); Egfr (through Colorectal Cancer, 20 shared stories on the weaker link); KRAS (through Colorectal Cancer, 20 shared stories on the weaker link).
Tracked since Jan 1, with coverage on 20 separate days — concentrated in Precision Medicine and Pubmed Targeted.